Baltimore, MARYLAND2 Active Studies

Prader-Willi Syndrome Clinical Trials in Baltimore, MARYLAND

Find 2 actively recruiting prader-willi syndrome clinical trials in Baltimore, MARYLAND. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
192
Enrolling

Recruiting Prader-Willi Syndrome Studies in Baltimore

About Prader-Willi Syndrome Clinical Trials in Baltimore

Prader-Willi syndrome is a rare genetic disorder caused by loss of gene function on chromosome 15, leading to constant hunger, obesity, intellectual disability, and short stature. It is the most common genetic cause of life-threatening obesity. Management includes growth hormone therapy and strict dietary supervision.

There are currently 2 prader-willi syndrome clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 192 participants. Research is being sponsored by Foundation for Prader-Willi Research, Aardvark Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prader-Willi Syndrome Clinical Trials in Baltimore — FAQ

Are there prader-willi syndrome clinical trials in Baltimore?

Yes, there are 2 prader-willi syndrome clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What prader-willi syndrome treatments are being tested?

The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for prader-willi syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov